🇦🇺Australia

GMP CAPA Non-Compliance Fines

2 verified sources

Definition

Inadequate CAPA management in deviation investigations triggers TGA GMP compliance failures, resulting in batch rejections, rework, and inspection deficiencies.

Key Findings

  • Financial Impact: AUD 20,000-100,000 per GMP violation (batch rejection + rework costs); typical 2-5% production loss from deviations[3][6]
  • Frequency: Per TGA inspection or deviation event
  • Root Cause: Manual CAPA processes fail root cause analysis and timely closure, violating PIC/S standards

Why This Matters

The Pitch: Pharmaceutical players in Australia waste AUD 50,000+ annually on CAPA rework and GMP violations. Automation of deviation investigation eliminates this risk.

Affected Stakeholders

Quality Manager, Manufacturing Head, Compliance Officer

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Request Deep Analysis

🇦🇺 Be first to access this market's intelligence